NASDAQ:MSON - Misonix Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $28.00
  • Forecasted Upside: 5.50 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$26.54
+0.30 (1.20%)
Get New Misonix Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MSON and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MSON

Analyst Price Target is $28.00
▲ +5.50% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Misonix in the last 3 months. The average price target is $28.00, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 5.50% upside from the last price of $26.54.

This chart shows the closing price for MSON for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 2 contributing investment analysts is to hold stock in Misonix. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
12/4/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
3/4/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
6/2/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
8/31/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
11/29/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
2/27/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/28/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
5/28/2022

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/2/2021BTIG ResearchDowngradeBuy ➝ NeutralHigh
7/30/2021Craig HallumDowngradeBuy ➝ Hold$23.00 ➝ $28.00High
10/6/2020BTIG ResearchReiterated RatingBuy$18.00High
7/13/2020Craig HallumBoost Price TargetBuy$18.00 ➝ $23.00Low
7/10/2020BTIG ResearchReiterated RatingBuy$18.00High
4/3/2020Craig HallumLower Price Target$28.00 ➝ $13.00High
4/3/2020BTIG ResearchLower Price TargetHold ➝ Buy$27.00 ➝ $18.00Low
8/15/2019BTIG ResearchReiterated RatingBuy$27.00High
6/12/2019BTIG ResearchInitiated CoverageBuy ➝ Buy$29.00Medium
9/11/2018Craig HallumInitiated CoverageBuy$28.00High
(Data available from 5/28/2017 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/30/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/29/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/29/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/28/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/27/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/29/2022
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/28/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/28/2022

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Misonix logo
Misonix, Inc. is a medical device company, which engages in the design, development, manufacture and marketing of therapeutic ultrasonic medical devices. It operates through the following segments: Surgical and Wound. The Surgical segment consists of BoneScalpel and SonaStar products. The Wound segment consists of SonicOne, TheraSkin and Therion products. The company's ultrasonic medical devices are used in the following surgeries: spine, neuro, orthopedic, wound debridement, cosmetic, laparoscopic, and medical applications. Misonix was founded by Howard Alliger in 1959 and is headquartered in Farmingdale, NY.
Read More

Today's Range

Now: $26.54
Low: $26.54
High: $26.54

50 Day Range

MA: $26.18
Low: $24.89
High: $26.54

52 Week Range

Now: $26.54
Low: $11.04
High: $26.99

Volume

2 shs

Average Volume

60,302 shs

Market Capitalization

$462.06 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.36

Frequently Asked Questions

What sell-side analysts currently cover shares of Misonix?

The following Wall Street research analysts have issued reports on Misonix in the last twelve months: BTIG Research, Craig Hallum, and StockNews.com.
View the latest analyst ratings for MSON.

What is the current price target for Misonix?

0 Wall Street analysts have set twelve-month price targets for Misonix in the last year. Their average twelve-month price target is $28.00, suggesting a possible upside of 5.5%.
View the latest price targets for MSON.

What is the current consensus analyst rating for Misonix?

Misonix currently has 2 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in MSON, but not buy more shares or sell existing shares.
View the latest ratings for MSON.

How do I contact Misonix's investor relations team?

Misonix's physical mailing address is 1938 NEW HIGHWAY, FARMINGDALE NY, 11735. The medical equipment provider's listed phone number is (631) 694-9555. The official website for Misonix is www.misonix.com. Learn More about contacing Misonix investor relations.